Contact Us

Making Medicine Available


The 340B Drug Pricing Program was established to permit covered entities “to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” 340B offers meaningful savings to uninsured patients on their medications (average 50% off), and can generate significant revenue to the safety net providers who take care of them. 340B is available to all FQHCs, DSH Hospitals, and several other types of providers. Check if your organization is eligible.


NYCRx was started by the New York City Department of Health and Mental Hygiene with seed funding from HRSA, the Federal office that oversees the Office of Pharmacy Affairs and the 340B program. NYCRx was launched to address the serious underutilization of 340B by eligible entities.

In 2007, NYCRx was spun off and incorporated as an independent 501c3. We were started with the explicit mission to expand use of the 340B program.


Since then, we now partner with 55 health centers, working with more than 60 pharmacies.

In addition to 340B services and prescription discount offerings, we have expanded into mission appropriate projects that relate to expanding access to medical prescriptions.

Our Mission

Our mission is to provide access to low-cost prescriptions to the medically underserved, and to support eligible safety net providers in maximizing the use of the 340B drug discount program.

Sarah Sheffield

Executive Director

Sarah has been working on NYCRx since its inception in 2005, through its incorporation in 2007 and has served as the Executive Director of NYCRx since January 2009.

Prior to joining NYCRx, Sarah served as the Director of Policy and Strategic Initiatives for the Division of Health Promotion and Disease Prevention at the New York City Department of Health and Mental Hygiene. She worked mainly with the Bureau of Chronic Disease Prevention and Control, where she helped launch their first citywide public health detailing campaign, and worked on the health task force on the Mayor's Commission for Economic Opportunity (CEO). Before joining the Health Department she worked in the policy department at the International AIDS Vaccine Initiative, where she wrote their policy brief on the economics of vaccine R&D.

She received her Masters in Public Administration at NYU's Wagner School of Public Service.

Board of Directors

Bill Martin
The former chief counsel for New York City Department of Mental Hygiene, and still consults with the City.
Peter Grisafi (Chair)
President and CEO, Damian Family Health Centers, a network of FQHCs that operates 5 clinic sites.
John Conry
Associate Clinical Professor, the Assistant Dean for Service Programs Director, Urban Pharmaceutical Care, Research and Education Institute St. John's University, College of Pharmacy and Allied Health Professions.
Jeff Lewis
COO at EHIM, and was previously President and COO at the Heinz Family Philanthropies.
Maurice Reid
President of KenJam Consultants LLC, Advisors to health care executives and Community Based Organizations (CBOs). He previously served as the President and CEO of the Brownsville Community Development Corporation's (BCDC).
Steven Alexander
COO, Deputy Executive Director of Bellevue Hospital Center, part of HHC.
Stuart Feldman
Professor Emeritus, Pharmacy and Public Health at the University of Georgia College of Public Health.
Jason Hardaway
Managing Partner at CiiTA, a consulting practice for stakeholders in the 340B Drug Discount Program.


Health Resources and Services Administration (HRSA)
New York State Health Foundation
The Peter and Carmen Lucia Buck Foundation
New York Community Trust

Tax Forms

2012 990 Form